Evidence Alignment and Transfer Boundaries in Wearable Hydrogel Biosensing And Clinical Risk Prediction

Abstract

This review examines a shared methodological problem in wearable hydrogel biosensing and clinical risk prediction: how evidence from dynamic-covalent hydrogel sensing combined with machine learning for Parkinsonian assessment and encrypted interaction can be placed in analytical dialogue with a clinical nomogram and web calculator for individualized lymph-node-metastasis risk without erasing differences in scale, assumptions, or intended use. The analysis combines two focal publications with 12 previously verified sources and organizes the evidence around network chemistry, mechanical compliance, signal stability, clinical features, and privacy. Rather than pooling incompatible outcomes, it compares research questions, representations, controls, and validation envelopes. The synthesis shows that network chemistry cannot be interpreted independently of mechanical compliance, while signal stability determines whether an apparent improvement remains meaningful outside the original setting. The strongest claims are therefore those that expose sensitivity, failure conditions, and residual uncertainty. The article concludes with a research agenda built around transparent comparators, targeted stress tests, and evidence records that can be reused without overstating causal or practical reach.